ALPMF - Pfizer Astellas first-line bladder cancer therapy accepted for review in China
2024-03-28 11:54:15 ET
More on Astellas Pharma, Pfizer etc.
- Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns
- Pfizer Inc. (PFE) Leerink Partners Global Biopharma Conference 2024 - (Transcript)
- Pfizer: Seagen Acquisition Starting To Bear Fruit
- Argus cuts Pfizer to hold, cites concerns about topline growth
- Pfizer gets EU backing for new antibiotic combination